Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF – Get Free Report) was the recipient of a large drop in short interest during the month of October. As of October 30th, there was short interest totaling 56,877 shares, a drop of 41.9% from the October 15th total of 97,838 shares. Based on an average trading volume of 44,025 shares, the short-interest ratio is presently 1.3 days. Currently, 0.0% of the company’s shares are short sold.
Sernova Biotherapeutics Price Performance
Shares of Sernova Biotherapeutics stock opened at $0.07 on Tuesday. The stock’s fifty day moving average is $0.08 and its two-hundred day moving average is $0.10. The company has a market capitalization of $26.74 million, a PE ratio of -1.77 and a beta of 0.90. Sernova Biotherapeutics has a 52 week low of $0.06 and a 52 week high of $0.14.
Sernova Biotherapeutics (OTCMKTS:SEOVF – Get Free Report) last released its earnings results on Thursday, September 10th. The company reported ($0.01) earnings per share for the quarter, hitting the consensus estimate of ($0.01).
About Sernova Biotherapeutics
Sernova Biotherapeutics is a Canadian biotechnology company developing regenerative medicine technologies that use therapeutic cells to treat chronic diseases. Its primary platform, the Cell Pouch System, is an implantable device designed to support blood-vessel growth around transplanted cells. The company has focused on combining the Cell Pouch with insulin-producing islet cells as a potential treatment for type 1 diabetes. Its research has also included cell-based approaches for other conditions, such as thyroid disease and hemophilia.
See Also
- Five stocks we like better than Sernova Biotherapeutics
- Tyson Foods’ Earnings Beat Hides a Warning for Consumer Staples Dividend Investors
- 3 Stocks in an Overlooked Corner of Infrastructure With Hundreds of Billions at Stake
- Tyson Foods’ 10% Surge Puts a Breakout in Sight, But Wall Street Remains Cautious
- Microsoft’s Outage Barely Moved Its Stock, But a Bigger Risk May Be Building
Receive News & Ratings for Sernova Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
